Yingjie Bian

11PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 22, 2026
CCL3 and IL-7 Synergistically Enhance CAR-T Efficacy in Solid Tumors.

|May 22, 2026
Iron overload in the tumor microenvironment induces CD8+ T cell ferroptosis and dysfunction.

|Dec 13, 2025
Author Correction: Cancer SLC43A2 alters T cell methionine metabolism and histone methylation.

Yingjie Bian, Wei Li, Daniel M Kremer

|Jan 05, 2021
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination.

Jiali Yu, Michael D Green, Shasha Li

|Sep 04, 2020
Cancer SLC43A2 alters T cell methionine metabolism and histone methylation.

Yingjie Bian, Wei Li, Daniel M Kremer

|Apr 03, 2020
Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control.

Zhichen Sun, Zhenhua Ren, Kaiting Yang

Pageof 2

Frequent Collaborators

4 joint publications

Yang-Xin Fu

3 joint publications

Ilona Kryczek

3 joint publications

Weiping Zou

3 joint publications

Hua Peng